ADC Therapeutics SA Cash on Hand 2019-2022 | ADCT
ADC Therapeutics SA cash on hand from 2019 to 2022. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
ADC Therapeutics SA Annual Cash on Hand
(Millions of US $) |
| 2021 |
$467 |
| 2020 |
$439 |
| 2019 |
$116 |
| 2018 |
$139 |
ADC Therapeutics SA Quarterly Cash on Hand
(Millions of US $) |
| 2022-03-31 |
$431 |
| 2021-12-31 |
$467 |
| 2021-09-30 |
$530 |
| 2021-06-30 |
$372 |
| 2021-03-31 |
$383 |
| 2020-12-31 |
$439 |
| 2020-09-30 |
$494 |
| 2020-06-30 |
$349 |
| 2020-03-31 |
|
| 2019-12-31 |
|
| 2019-09-30 |
|
| 2019-06-30 |
|
| 2018-12-31 |
$139 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.000B |
$0.034B |
|
ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.
|
